social media network

education learning

corporate business

government public service

healthcare medical

English

li_alerts

lidc

li_gc

bcookie

bscookie

lang

JSESSIONID

Within the commercial generic top-level domain (.com), 'fr.linkedin.com' is registered with subdomain 'fr'. Its registrable label 'linkedin' stretches across 8 characters split between 3 vowels and 5 consonants. Breaking it apart gives 2 words: linked, in. Expect 4 characters per word on average. No strong language cues emerged from the frequency lists.

loginCsrfParam

session_key

session_password

session_redirect

controlId

pageInstance

html/9c/1c/9c1c3c69-0a68-4d26-9814-5e02933f47f1.html.gz

default-src 'none'; connect-src 'self' *.licdn.com *.linkedin.com cdn.linkedin.oribi.io dpm.demdex.net/id lnkd.demdex.net blob: accounts.google.com/gsi/ linkedin.sc.omtrdc.net/b/ss/ v.clarity.ms/collect *.microsoft.com *.adnxs.com *.tealiumiq.com login.microsoftonline.com bat.bing.com lnkd.tt.omtrdc.net/rest/v1/delivery www.google.com google.com adservice.google.com pagead2.googlesyndication.com td.doubleclick.net www.googletagmanager.com www.googleadservices.com ad.doubleclick.net googleads.g.doubleclick.net; script-src 'report-sample' 'sha256-th47JTnh6tX15SUn/I+GGmsOSXpa7dh5Skner77gxlY=' 'sha256-SSoodjUD3LGm2FfFCVHGqEb8D4UM3OOigidT2UKDcYg=' 'sha256-cKTgdnmO6+hXd85a9wKg1effVfVzenUAtUCyOKY9bQE=' 'sha256-DwtT8+ZZKpxH9pqZNAmJ3GdbLAh5SsYaXR3omTXPCns=' 'sha256-sV9jZa797T0QWBzcU/CNd4tpBhTnh+TFdLnfjlitl28=' 'sha256-aa/Q8CRBDSqTQbCIyioPhZaz+G+dbPyu7BzsjInEmiU=' 'sha256-THuVhwbXPeTR0HszASqMOnIyxqEgvGyBwSPBKBF/iMc=' 'sha256-zTIusdVJJeXz9+iox2a+pdDglzbpRpFVRzEwvW4AONk=' 'sha256-iC8MPqNLw0FDnsBf4DlSkFLNTwhkI85aouiAEB819ic=' 'sha256-2EqrEvcPzl8c6/TSGVvaVMEe7lg700MAz/te4/3kTYY=' 'sha256-y5uW69VItKj51mcc7UD9qfptDVUqicZL+bItEpvVNDw=' 'sha256-DatsFGoJ8gFkzzxo47Ou76WZ+3QBPOQHtBu9p9b3DhA=' 'sha256-k95cyM8gFgPziZe5VQ2IvJvBUVyd5zFt2CokIUwqdHE=' 'sha256-PyCXNcEkzRWqbiNr087fizmiBBrq9O6GGD8eV3P09Ik=' 'sha256-RFqsjmAF1N5LnfpaHFvPqFlVkeIS/DtTAFor+JjJJVc=' 'sha256-2SQ55Erm3CPCb+k03EpNxU9bdV3XL9TnVTriDs7INZ4=' 'sha256-S/KSPe186K/1B0JEjbIXcCdpB97krdzX05S+dHnQjUs=' 'sha256-9pXOIwF4N0gPltLd3AI69lkCjSC2H/Eb3sc5zdmUyYU=' 'sha256-jou6v/Nleyzoc+LXktAv1Fp8M807dVVxy7E/yzVljHc=' 'sha256-6E4e/3dSvj/8JZT2S2yR91mspqM6MyOpKl5lrhHsZa8=' 'sha256-JfJ82reKxtqugVbfRGw/O/1x1Lm1I09rHueXSwvbRws=' 'sha256-BbV1i75oYRtLtfDWs7tnA8QLF5EOO1dVHKL0prVd/fQ=' 'sha256-3woF8BZ54TeXM+czaH3aXoaJsVpiamuAKFsXDykAR/Q=' 'sha256-vIfNcKb8ixJg1cfJIoNNYjWcm0lezj1/XpUNFiZyVsU=' 'sha256-cLsHUHFgT/VGX04cZrJ9xgm4HbzTR7ptutkxK+7BlMk=' 'sha256-BwU8jMnQYUhjOpsDVABpfddV/DlP1ZYrFcTumYw7x54=' 'sha256-wz6ika9i3WU3bpUPdhYDZeO/NrDQniDyiscN0LWnyaY=' 'sha256-3RIGhhApBii1KY+aW1xk7kFyoQY8vSVE5DfT7E9SJUc=' static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com platform.linkedin.com platform-akam.linkedin.com platform-ecst.linkedin.com platform-azur.linkedin.com snap.licdn.com www.google.com/recaptcha/enterprise.js www.gstatic.com/recaptcha/releases/ www.googletagmanager.com/gtag/js www.googleadservices.com/pagead/ www.google.com/pagead/ googleads.g.doubleclick.net/pagead/ adservice.google.com/pagead/ pagead2.googlesyndication.com/pagead/ www.googletagmanager.com/gtag/destination merchantpool1.linkedin.com/mdt.js; img-src data: blob: * android-webview-video-poster:; font-src data: *; style-src 'self' 'unsafe-inline' static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com; media-src 'self' *.licdn.com *.lynda.com; worker-src 'self' blob: static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com; frame-src 'self' www.youtube.com/embed/ www.youtube-nocookie.com/embed/ lnkd.demdex.net smartlock.google.com accounts.google.com player.vimeo.com *.linkedin.com www.slideshare.net *.megaphone.fm *.omny.fm *.sounder.fm msit.powerbi.com app.powerbi.com linkedin.github.io *.licdn.com *.adnxs.com acdn.adnxs-simple.com radar.cedexis.com edge-auth.microsoft.com flo.uri.sh play.vidyard.com www.google.com/recaptcha/ aat-acr-web-prod.azurewebsites.net *.fls.doubleclick.net www.googletagmanager.com td.doubleclick.net li.protechts.net *.xlgmedia.com *.px-cloud.net merchantpool1.linkedin.com; frame-ancestors 'self' *.www.linkedin.com:*; manifest-src 'self'; report-uri https://www.linkedin.com/security/csp?f=gg

Sign in with Google Button

b06afe5d1a9853b5a343b7118b9c641a78004921d38b002349b102727437771b

8ba28cf9a72967200e52e9925d8106f44786c9dc1a50fc3cb7557370c2d6af15

9b4ee259dba330297213fb2a7986c0e9cd9fdbbaa3745ebdfce48d891f09f297

ea5660251743cbe2d86f28514b75cf33a2cc415b8360bbb352a9cce4e3abb602

3aea2efa28a6c1ce964301fc7264ac01a38b63d2b98f65f53e3877157249ec0c

9c317a75d3e13ef5b6248eec3fb28852c35fb37bdbe8f449700824eb2fd0ebf6

25f27cdab78ac6daae8156df446c3f3bfd71d4b9b5234f6b1ee7974b0bdb470b

1283f6e18c2ed5f42e3f19be3e82e69d20fcf4d093dae3abca28bbccfa5e85fd

pageKey

robots

bingbot

linkedin:pageTag

locale

https://fr.linkedin.com/in/paulhudsonprofile

viewport

litmsProfileName

https://static.licdn.com/aero-v1/sc/h/38k9mj3cvikmihkcx9uvp3bqc

ubba

https://static.licdn.com/aero-v1/sc/h/1ny8qa2mxece9t1gr32iph525

platform

https://static.licdn.com/aero-v1/sc/h/7nirg34a8ey4y2l4rw7xgwxx4

platform-worker

Chief Executive Officer at Sanofi · I was drawn to healthcare early in my career. While a lot has changed since I started as a pharmaceutical medical representative 30 years ago, I remain inspired everyday by the power of medicine and how new technology, like Artificial Intelligence, is helping advance scientific breakthroughs like never before.  
 
I am proud to lead Sanofi, a global healthcare company driven by one purpose: we chase the miracles of science to improve people’s lives. That means our teams are dedicated to transforming the practice of medicine by turning the impossible into the possible.  
 
As a leader, I firmly believe that making an impact starts with culture - how we empower and motivate each other to be the best version of ourselves. That includes giving our people access to cutting edge technologies that push the boundaries of science. Then, with open minds, we can fuel innovation and unleash potential that drives long-term success.  
 
What do I love most about my job? That even on a tough day, I am confident that our work is making a positive impact on our people, our patients and our society. · Expérience : Sanofi · Formation : The Manchester Metropolitan University · Lieu : Paris et périphérie · 500 relations ou plus sur LinkedIn. Consultez le profil de Paul Hudson sur LinkedIn, une communauté professionnelle d’un milliard de membres.

description

og:description

twitter:description

Paul Hudson - Chief Executive Officer at Sanofi | LinkedIn

https://media.licdn.com/dms/image/v2/D4E03AQFJeSF97Rn65A/profile-displayphoto-shrink_200_200/profile-displayphoto-shrink_200_200/0/1701246507572?e=2147483647&v=beta&t=kURhhdquEKlF9Ut7nf4Ea1XGwJd3PpdL1OOhqePS7iQ

twitter:card

twitter:site

twitter:title

twitter:image

clientSideIngraphs

HSTS header missing - vulnerable to protocol downgrade attacks

CSP header missing - vulnerable to XSS attacks

html/9c/1c/9c1c3c69-0a68-4d26-9814-5e02933f47f1_nodriver.html.gz

fr.linkedin.com

MarkMonitor Inc.

LINKEDIN.COM

Abuse

Admin

Cloudflare-NOC

Cloudflare, Inc.

CLOUDFLARENET


          function getDfd() {let yFn,nFn;const p=new Promise(function(y, n){yFn=y;nFn=n;});p.resolve=yFn;p.reject=nFn;return p;}
          window.lazyloader = getDfd();
          window.tracking = getDfd();
          window.impressionTracking = getDfd();
          window.ingraphTracking = getDfd();
          window.appDetection = getDfd();
          window.pemTracking = getDfd();
          window.appRedirectCompleted = getDfd();
        

Beyond the Screen: Leveraging Tech to Unlock Happiness 

From Pit Stops to Patients: When Every Second Counts  

Who Ignites Your Potential? 

Shining a Light on Science and Innovation

Celebrating Sports, Spirit and Shared Values

Our journey to become a science-led company

Giving our people the chance of a lifetime to give back

We Are Only as Good as the Sum of Our Parts

Let’s Fly the Meningitis Flag

1 Year to Paris 2024: Ready, Set, Go! 

Our fourth quarter and full year results are in, reflecting another strong year of profitable growth. We delivered on our strategy with relentless focus on our pipeline.  

In 2025, we launched three new medicines and vaccines, providing innovative options to patients with rare diseases and for COVID-19 prevention.  

We’re in healthcare to push the boundaries of science. This past year proved that we're expanding into the bold, uncharted territory where transformative innovation begins. We’ve made tremendous progress, but there’s still important work ahead of us.  

Thank you to all the Sanofi teams worldwide. Your incredible work is driving real progress for patients and showcasing our evolution as an R&D-driven, AI-powered biopharma company. 

More details in the comments ⬇️ 

#SanofiResults #FinancialResults

Davos #WEF26 delivered again! A week of critical conversations that will shape the future of healthcare. 
 
I spent my time meeting with government officials, business leaders, partners, and journalists to ensure healthcare is at the top of their agendas. Here are the convictions I shared:  

📌 𝐄𝐮𝐫𝐨𝐩𝐞 𝐡𝐚𝐬 𝐭𝐡𝐞 𝐬𝐤𝐢𝐥𝐥𝐬 𝐚𝐧𝐝 𝐜𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬 𝐭𝐨 𝐥𝐞𝐚𝐝 𝐢𝐧 𝐡𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐨𝐯𝐞𝐫𝐞𝐢𝐠𝐧𝐭𝐲. To stay competitive and a hub for innovation, it needs to act and execute with urgency. Speed and unity matter. This is a pivotal moment in history, one not to squander. More in my WEF panel: https://lnkd.in/eFbdR3hG

📌 𝐖𝐞 𝐦𝐮𝐬𝐭 𝐛𝐮𝐢𝐥𝐝 𝐬𝐭𝐫𝐨𝐧𝐠 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 𝐰𝐢𝐭𝐡 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭𝐬 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐞 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐫𝐞𝐚𝐜𝐡𝐞𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐢𝐧 𝐧𝐞𝐞𝐝. Finding smarter, faster breakthrough therapies to fight diseases takes years, costs billions, and succeeds only in a small percentage of cases. That’s why when we make a scientific breakthrough, these partnerships become critical in securing availability and affordability globally. Hear more on France Info: https://lnkd.in/e2PefkkA

📌 𝐀𝐈 𝐢𝐬 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐭 𝐚𝐧 𝐮𝐧𝐩𝐫𝐞𝐜𝐞𝐝𝐞𝐧𝐭𝐞𝐝 𝐬𝐩𝐞𝐞𝐝 𝐚𝐧𝐝 𝐰𝐢𝐭𝐡 𝐭𝐚𝐧𝐠𝐢𝐛𝐥𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬. At Sanofi, we’re significantly reducing time between the discovery of a new molecule and the moment it becomes a therapy available for patients. And this is just the beginning. More in my interview with CNBC: https://lnkd.in/erZjMEgw 
 
That's the formal agenda. But what I also like about the World Economic Forum, is that in many ways, it runs on serendipity. You bump into someone between sessions, exchange a few words, cross paths again while ordering coffee. By the end of the week, a passing comment has become something tangible: a new idea, a new partnership, a new way to reach patients faster.


It’s always a pleasure when I get the opportunity to sit down with Zak Brown. Especially to discuss what our 3-year partnership with McLaren Racing has meant for the important work we do every day on behalf of patients.  
 
Our shared ambition for going further, faster, and with more precision, has fueled our purpose to improve people's lives and given us critical insights we need to develop the next generation of best-in-class medicines and vaccines.
 
Exciting times are ahead as we continue to explore new ways we can drive innovation forward, together. 🏎️🔬

Check out highlights from our conversation in the clip below or watch the full video here 🎥:  https://lnkd.in/ef_vksgA

Today we announced Sanofi's Q3 results - proof of our continued growth momentum.

In addition to our strong sales growth of 7%, here's what stands out:  
-3 new medicines added to our portfolio 
-8 new regulatory submissions
-3 new phase 3 trials initiated
-2 medicines on track to achieve blockbuster status 

And 1 million patients treated for non-communicable diseases across more than 40 low- and middle-income countries. 

As an R&D-driven, AI-powered biopharma company, we never lose sight of what truly drives each of us: improving people’s lives. We do that by chasing the miracles of science every day for the millions of patients who are counting on us. 

Thanks to all Sanofians for their hard work and dedication! 

Check out the video below and read more about our results here: https://lnkd.in/egv-GswY
 
#SanofiResults #FinancialResults

I am proud to share the news of Sanofi’s additional $625 million, multi-year capital commitment to Sanofi Ventures. This investment strengthens our ability to support early-stage biotech and digital health companies, reflecting our belief that breakthroughs often begin at the earliest stages of innovation. 
 
At a time when access to funding has become more limited across the biotech sector, deepening our investments in pioneering healthcare companies is critical to accelerate the development of next-generation therapies. 

I want to thank Monika Vnuk, Jason P. Hafler and the whole Sanofi Ventures team whose work is driving a powerful engine for scientific progress that improves people’s lives. 

You can learn more in the press release here: https://lnkd.in/ee_wv4W2 

#Innovation #DigitalHealth #AI

Paul Hudson

Novartis

AstraZeneca

The Manchester Metropolitan University

I was drawn to healthcare early in my career. While a lot has changed since I started as a pharmaceutical medical representative 30 years ago, I remain inspired everyday by the power of medicine and how new technology, like Artificial Intelligence, is helping advance scientific breakthroughs like never before. I am proud to lead Sanofi, a global healthcare company driven by one purpose: we chase the miracles of science to improve people’s lives. That means our teams are dedicated to transforming the practice of medicine by turning the impossible into the possible. As a leader, I firmly believe that making an impact starts with culture - how we empower and motivate each other to be the best version of ourselves. That includes giving our people access to cutting edge technologies that push the boundaries of science. Then, with open minds, we can fuel innovation and unleash potential that drives long-term success. What do I love most about my job? That even on a tough day, I am confident that our work is making a positive impact on our people, our patients and our society.

Requests	IP Address	Location	AS Autonomous System
137	13.107.246.44	United States	AS15169
137	1	-	-

Security Scan Report: fr.linkedin.com

Summary

AI Security Verdict

Safe Website

Safety Factors

Details

Screenshot

Page Load Overview

Language Analysis

Primary Language

Detection Details

Website Classification

Primary Category

All Detected Categories

Detected Features

Domain & IP Information

Detected Technologies7

Content Similarity HashesFor malware variant detection

TLSH (Trend Micro Locality Sensitive Hash)

ssdeep (Context Triggered Piecewise Hashing)

sdhash (Similarity Digest Hashing)

Image Hashes

Perceptual Hashes

Other Hashes

Scan History